New systemic treatments and new paradigms for PET-CT CPD

Info

Please note that for mobiles we stream the presentation slides and audio of the speaker.

Info

You must login to watch this lecture.

x Mobile version: slides + audio only
-15s 00:00 / 24:14 +15s
Minimise video

Professor Roland Hustinx gives an overview of FDG PET (fludeoxyglucose) as a surrogate pharmacodynamic indicator of target inhibition and discusses image-guided drug delivery.

This lecture was the '19th annual PET/CT meeting and section AGM' meeting at the Royal Society of Medicine in London.

Date of lecture: 14th March 2016

Length: 00:24:14

Tips about RSM Videos

  • This video is free to view for RSM Members, please log in before watching. There is a fee of £6.00 for Non-Members.
  • This video is linked to a CPD credit. Both RSM members and non-members must login before watching the video to be able to claim a CPD credit.
  • Click on the Slides tab to view all slides. You can make any slide larger by clicking on it.
  • Click on the Chapters tab to view different parts of the video.

Error

You must login to watch this lecture.

Error

You must login to watch this lecture.

46:47

Dr Bob Bury, Consultant Radiologist, Leeds Teaching Hospital.

Free Archived View
27:00

Yoav Medan, Associate Professor, Israel Institute of Technology.

Free Archived View
29:32

Professor Wladyslaw M Gedroyc, Imperial College London.

CPD Archived View
44:58

Professor Irene Tracey, Oxford University

CPD Archived View
21:50

Professor Gail Ter Haar, Scientific Director, and Dr David Cranston, Clinical Director; Churchill Hospital Oxford. 

Free Archived View
18:49

Olga Kubassova, Founder and CEO of Image Analysis. 

Free Archived View
54:38

Mike Blayney, Consultant Anaesthetist, Noble's Hospital, Isle of Man.

CPD View
25:00

Claire Webster, Specialist Trainee in Vascular Surgery, London Deanery. 

CPD View
20:48

Andy Planner, Consultant Radiologist, Great Western Hospital, Swindon.

CPD View

Error

You must login to watch this lecture.